Pricing

Acorda Therapeutics Inc (ACORQ)

followers ·
Sector: HEALTH CARE
Industry: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO: Ronald Cohen
Employees: 130
Web site: acorda.com
TWO BLUE HILL PLAZA, PEARL RIVER, NY, 10965
914-347-4300

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Stock Split History
Date Ratio
2021-01-04 1:6
2023-06-05 1:20
All 13F Filers Prior Change Hedge Funds 1 Prior Change
Acorda Therapeutics, Inc. develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS) Inbrija for the treatment of OFF periods in Parkinson's disease in Europe.
Please log in first to see chart
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% Change in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available